Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Estimating the Burden of Venous and Arterial Thrombotic Events in Hospitalized Adults with COVID-19; A National Multicenter Cohort Study

Rushad Patell, Dana E. Angelini, Stacy R Ellsworth, Paul Lewis, James C Lee, Edith A. Nutescu, Alpesh Amin, Daniel M Witt, Marisol Betensky, Neil Goldenberg, Peter Kouides, Doaa Attia, MD, Lyla Mourany, Leslie Lake, Rachel P. Rosovsky, Alok A. Khorana, Scott Kaatz

Blood (2023) 142 (Supplement 1): 1262.

https://doi.org/10.1182/blood-2023-187029

Published: 2023

Journal Articles

Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Anti-B-Cell Maturation Antigen (BCMA)-Exposed Cohort of the CC-220-MM-001 Trial

Sagar Lonial, Al-Ola Abdallah, Faiz Anwer, Ashraf Z. Badros, Manisha Bhutani, Abdullah Khan, Brea Lipe, Albert Oriol, Darrell White, Michael Amatangelo, Kexin Jin, Mark Masin, Vi Nguyen, Alpesh Amin, Paulo Maciag, Niels WCJ Van De Donk

Blood (2022) 140 (Supplement 1): 4398–4400.

https://doi.org/10.1182/blood-2022-158180

Published: 2022

Journal Articles

Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Dose-Expansion Phase of the CC-220-MM-001 Trial

Blood (2021) 138 (Supplement 1): 162.

https://doi.org/10.1182/blood-2021-147704

Published: 2021

Journal Articles

VTE Prophylaxis Across the Continuum of Care in US Medical Patients at Risk of Venous Thromboembolism.

Alpesh Amin, MD, MBA, FACP, Jay Lin, PhD, MBA, Amy Ryan

Blood (2009) 114 (22): 1386.

https://doi.org/10.1182/blood.V114.22.1386.1386

Published: 2009

Journal Articles

VTE Prophylaxis Across the Continuum of Care in US Orthopedic Surgery Patients.

Alpesh Amin, MD, MBA, FACP, Jay Lin, PhD, MBA, Amy Ryan

Blood (2009) 114 (22): 2097.

https://doi.org/10.1182/blood.V114.22.2097.2097

Published: 2009

Journal Articles

Clinical and Economic Outcomes Following Full or Partial ACCP Recommended Prophylaxis in Cancer Patients at Risk of Venous Thromboembolism

Alpesh Amin, MD, MBA, FACP, Jay Lin, PhD, MBA, Guiping Yang, Steve Stemkowski, MHA

Blood (2008) 112 (11): 169.

https://doi.org/10.1182/blood.V112.11.169.169

Published: 2008

Journal Articles

Economic Outcomes in Patients at Risk for Venous Thromboembolism Receiving Appropriate Enoxaparin or Unfractionated Heparin Prophylaxis

Alpesh Amin, MD, MBA, FACP, Jay Lin, PhD, MBA, Greg Lenhart, Kathy Schulman

Blood (2008) 112 (11): 1285.

https://doi.org/10.1182/blood.V112.11.1285.1285

Published: 2008

Journal Articles

Are Hospitals Following Guidelines for VTE Prevention? the Veneous Thromoembolism Study to Assess the Rate of Thromboprophylaxis

Alpesh Amin, MD, MBA, FACP, Alex Spyropoulos, MD, FACP, FCCP, Paul Dobesh, PharmD, FCCP, BCPS, Andrew Shorr, MD, Mohamed Hussein, Ms.C.S., M.S.P.H, Ph.D., Essy Mozaffari, PharmD, MPH, Joshua Benner, PharmD, ScD

Blood (2008) 112 (11): 1286.

https://doi.org/10.1182/blood.V112.11.1286.1286

Published: 2008

Journal Articles

Appropriate VTE Prophylaxis Is Associated with Lower Direct Medical Costs among Medical and Surgical Patients in the United States.

Alpesh Amin, MD, MBA, FACP, Mohamed Hussein, Ms.C.S., M.S.P.H, Ph.D., David Battleman, MD, Jay Lin, PhD, MBA, Steve Stemkowski, MHA, Geno J Merli, MD

Blood (2008) 112 (11): 1287.

https://doi.org/10.1182/blood.V112.11.1287.1287

Published: 2008

Journal Articles

Prolonged Survival of a Patient with De Novo Acute Myeloid Leukemia (AML) and Trisomy 13 with Intensive Chemotherapy and Autologous Peripheral Blood Transplantation (PBSCT): A Case Report.

Nitin D. Joshi, MD, Alpesh Amin, MD, Rajneesh Nath, MD

Blood (2005) 106 (11): 4519.

https://doi.org/10.1182/blood.V106.11.4519.4519

Published: 2005

NARROW

Estimating the Burden of Venous and Arterial Thrombotic Events in Hospitalized Adults with COVID-19; A National Multicenter Cohort Study

Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Anti-B-Cell Maturation Antigen (BCMA)-Exposed Cohort of the CC-220-MM-001 Trial

Iberdomide (IBER) in Combination with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Dose-Expansion Phase of the CC-220-MM-001 Trial

VTE Prophylaxis Across the Continuum of Care in US Medical Patients at Risk of Venous Thromboembolism.

VTE Prophylaxis Across the Continuum of Care in US Orthopedic Surgery Patients.

Clinical and Economic Outcomes Following Full or Partial ACCP Recommended Prophylaxis in Cancer Patients at Risk of Venous Thromboembolism

Economic Outcomes in Patients at Risk for Venous Thromboembolism Receiving Appropriate Enoxaparin or Unfractionated Heparin Prophylaxis

Are Hospitals Following Guidelines for VTE Prevention? the Veneous Thromoembolism Study to Assess the Rate of Thromboprophylaxis

Appropriate VTE Prophylaxis Is Associated with Lower Direct Medical Costs among Medical and Surgical Patients in the United States.

Prolonged Survival of a Patient with De Novo Acute Myeloid Leukemia (AML) and Trisomy 13 with Intensive Chemotherapy and Autologous Peripheral Blood Transplantation (PBSCT): A Case Report.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only